Recommendations for pediatric tuberculosis vaccination in Italy

References

• World Health Organization. Global Tuberculosis Report 2014. Document WHO/HTM/TB/2014.08 Geneva: World Health Organization, 2014
   Google Scholar
• Calmette A, Guerin C, Boquet A, Nègre L. La vaccination préventive contre la tuberculose par le BCG. Paris: Masson et Cie. 1927
   Google Scholar
• Behr MA. BCG – different strains, different vaccines? Lancet Infect Dis 2002; 2:86-92; PMID:11901655; http://dx.doi.org/10.1016/S1473-3099(02)00182-2
   PubMed Web of Science ®Google Scholar
• Ritz N, Dutta B, Donath S, Casalaz D, Connell TG, Tebruegge M, Robins-Browne R, Hanekom WA, Britton WJ, Curtis N. The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial. Am J Respir Crit Care Med 2012; 185:213-22; PMID:22071384; http://dx.doi.org/10.1164/rccm.201104-0714OC
   PubMed Web of Science ®Google Scholar
• Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PE, Rodrigues LC, Smith PG, Lipman M, Whiting PF, et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis 2014; 58:470-80; PMID:24336911; http://dx.doi.org/10.1093/cid/cit790
   PubMed Web of Science ®Google Scholar
• Ottenhoff TH, Kaufmann SH. Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathog 2012; 8:e1002607; PMID:22589713; http://dx.doi.org/10.1371/journal.ppat.1002607
   PubMed Web of Science ®Google Scholar
• Liu J, Tran V, Leung AS, Alexander DC, Zhu B. BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy. Hum Vaccin 2009; 5:70-8; PMID:19164935; http://dx.doi.org/10.4161/hv.5.2.7210
   PubMed Web of Science ®Google Scholar
• Hesseling AC, Cotton MF, Fordham von Reyn C, Graham SM, Gie RP, Hussey GD. Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants. Int J Tuberc Lung Dis 2008; 12:1376-79; PMID:19017445
   PubMed Web of Science ®Google Scholar
• Dalmia N, Ramsay AJ. Prime-boost approaches to tuberculosis vaccine development. Expert Rev Vaccines 2012; 11:1221-33; PMID:23176655; http://dx.doi.org/10.1586/erv.12.94
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control: Vaccine Schedule. Available at: http://vaccine-schedule.ecdc.europa.eu/Pages/Scheduler.aspx. Accessed 3 April 2015
   Google Scholar
• Il Programma Nazionale per le Linee Guida (PNLG). Methodological handbook – how to produce, disseminate and update clinical practice recommendations. http://www.pnlg.it/en_method. Accessed 30 December 2014
   Google Scholar
• Scottish Intercollegiate Guidelines Netwok (SIGN). Available at http://www.sign.ac.uk/. Accessed 30 December 2014
   Google Scholar
• Guidelines for the planning and management of NIH Consensus Development Conferences Online Bethesda (MD): National Institutes of Health, Office of the Director, Office of Medical Applications of Research; 1993. Updated October 2001
   Google Scholar
• Colditz GA, Berkey CS, Mosteller F, Brewer TF, Wilson ME, Burdick E, Fineberg HV. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 1995; 96:29-35; PMID:7596718
   PubMed Web of Science ®Google Scholar
• Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 2006; 367:1173-80; PMID:16616560; http://dx.doi.org/10.1016/S0140-6736(06)68507-3
   PubMed Web of Science ®Google Scholar
• Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994; 271:698-702; PMID:8309034; http://dx.doi.org/10.1001/jama.1994.03510330076038
   PubMed Web of Science ®Google Scholar
• Abubakar I, Pimpin L, Ariti C, Beynon R, Mangtani P, Sterne JA, Fine PE, Smith PG, Lipman M, Elliman D, et al. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis. Health Technol Assess 2013; 17:1-372; PMID:24021245; http://dx.doi.org/10.3310/hta17370
   PubMed Web of Science ®Google Scholar
• Pereira SM, Barreto ML, Pilger D, Cruz AA, Sant'Anna C, Hijjar MA, Ichihara MY, Santos AC, Genser B, Rodrigues LC. Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial. Lancet Infect Dis 2012; 12:300-6; PMID:22071248; http://dx.doi.org/10.1016/S1473-3099(11)70285-7
   PubMed Web of Science ®Google Scholar
• Aronson NE, Santosham M, Comstock GW, Howard RS, Moulton LH, Rhoades ER, Harrison LH. Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study. JAMA 2004; 291:2086-91; PMID:15126436; http://dx.doi.org/10.1001/jama.291.17.2086
   PubMed Web of Science ®Google Scholar
• Abubakar I, Matthews T, Harmer D, Okereke E, Crawford K, Hall T, Collyns T, Smith G, Barrett A, Baugh S. Assessing the effect of foreign travel and protection by BCG vaccination on the spread of tuberculosis in a low incidence country, United Kingdom, October 2008 to December 2009. Euro Surveill 2011; 16: pii: 19826; PMID:21457684
   PubMedGoogle Scholar
• Kelekçi S, Karabel M, Karabel D, Hamidi C, Hoşoğlu S, Gürkan MF, Taş MA. Bacillus Calmette-Guérin is a preventive factor in mortality of childhood tuberculous meningitis. Int J Infect Dis 2014; 21:1-4; http://dx.doi.org/10.1016/j.ijid.2013.10.001
   PubMed Web of Science ®Google Scholar
• Gaensbauer JT, Vandaleur M, O'Neil M, Altaf A, Ní Chróinín M. BCG protects toddlers during a tuberculosis outbreak. Arch Dis Child 2009; 94:392-3; PMID:19190006; http://dx.doi.org/10.1136/adc.2008.145755
   PubMed Web of Science ®Google Scholar
• Brantsaeter AB, Romanus V, Andersen PH, Heldal E. Evidence of protective effect of BCG vaccination in persons at low risk of tuberculosis in Nordic countries. Int J Tuberc Lung Dis 2009; 13:440-5; PMID:19335948
   PubMed Web of Science ®Google Scholar
• Morán-Mendoza O, Marion SA, Elwood K, Patrick D, FitzGerald JM. Risk factors for developing tuberculosis: a 12-year follow-up of contacts of tuberculosis cases. Int J Tuberc Lung Dis 2010; 14:1112-9
   PubMed Web of Science ®Google Scholar
• Barreto ML, Cunha SS, Pereira SM, Genser B, Hijjar MA, Yury Ichihara M, de Brito SC, Dourado I, Cruz A, Santa'Ana C, et al. Neonatal BCG protection against tuberculosis lasts for 20 years in Brazil. Int J Tuberc Lung Dis 2005; 9:1171-3; PMID:16229231
   PubMed Web of Science ®Google Scholar
• Eriksen J, Chow JY, Mellis V, Whipp B, Walters S, Abrahamson E, Abubakar I. Protective effect of BCG vaccination in a nursery outbreak in 2009: time to reconsider the vaccination threshold? Thorax 2010; 65:1067-71; PMID:21030395; http://dx.doi.org/10.1136/thx.2010.140186
   PubMed Web of Science ®Google Scholar
• Basu Roy R, Sotgiu G, Altet-Gómez N, Tsolia M, Ruga E, Velizarova S, Kampmann B. Identifying predictors of interferon-γ release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin? A pTB-NET collaborative study. Am J Respir Crit Care Med 2012; 186:378-84; PMID:22700862; http://dx.doi.org/10.1164/rccm.201201-0026OC
   PubMed Web of Science ®Google Scholar
• Eisenhut M, Paranjothy S, Abubakar I, Bracebridge S, Lilley M, Mulla R, Lack K, Chalkley D, McEvoy M. BCG vaccination reduces risk of infection with Mycobacterium tuberculosis as detected by gamma interferon release assay. Vaccine 2009; 27:6116-20; PMID:19715782; http://dx.doi.org/10.1016/j.vaccine.2009.08.031
   PubMed Web of Science ®Google Scholar
• Soysal A, Millington KA, Bakir M, Dosanjh D, Aslan Y, Deeks JJ, Efe S, Staveley I, Ewer K, Lalvani A. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet 2005; 366:1443-51; PMID:16243089; http://dx.doi.org/10.1016/S0140-6736(05)67534-4
   PubMed Web of Science ®Google Scholar
• Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PE, Rodrigues LC, Smith PG, Lipman M, Whiting PF, et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis 2014; 58:470-80; PMID:24336911; http://dx.doi.org/10.1093/cid/cit790
   PubMed Web of Science ®Google Scholar
• Weir RE, Gorak-Stolinska P, Floyd S, Lalor MK, Stenson S, Branson K, Blitz R, Ben-Smith A, Fine PE, Dockrell HM. Persistence of the immune response induced by BCG vaccination. BMC Infect Dis 2008; 8:9; PMID:18221509; http://dx.doi.org/10.1186/1471-2334-8-9
   PubMed Web of Science ®Google Scholar
• Rodrigues LC, Pereira SM, Cunha SS, Genser B, Ichihara MY, de Brito SC, Hijjar MA, Dourado I, Cruz AA, Sant'Anna C, et al. Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial. Lancet 2005; 366: 1290-5; PMID:16214599; http://dx.doi.org/10.1016/S0140-6736(05)67145-0
   PubMed Web of Science ®Google Scholar
• Roth AE, Benn CS, Ravn H, Rodrigues A, Lisse IM, Yazdanbakhsh M, Whittle H, Aaby P. Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau. BMJ 2010; 340:c671; PMID:20231251; http://dx.doi.org/10.1136/bmj.c671
   PubMedGoogle Scholar
• Barreto ML, Pereira SM, Pilger D, Cruz AA, Cunha SS, Sant'Anna C, Ichihara MY, Genser B, Rodrigues LC. Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial. Vaccine 2011; 29:4875-7; PMID:21616115; http://dx.doi.org/10.1016/j.vaccine.2011.05.023
   PubMed Web of Science ®Google Scholar
• Leung CC, Tam CM, Chan SL, Chan-Yeung M, Chan CK, Chang KC. Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong. Int J Tuberc Lung Dis 2001; 5:717-23; PMID:11495262
   PubMed Web of Science ®Google Scholar
• Dantas OM, Ximenes RA, de Albuquerque Mde F, da Silva NL, Montarroyos UR, de Souza WV, Pereira TC, Campelo AR, Rodrigues LC. A case-control study of protection against tuberculosis by BCG revaccination in Recife, Brazil. Int J Tuberc Lung Dis 2006; 10:536-41; PMID:16704036
   PubMed Web of Science ®Google Scholar
• Hesseling AC, Rabie H, Marais BJ, Manders M, Lips M, Schaaf HS, Gie RP, Cotton MF, van Helden PD, Warren RM, et al. Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin Infect Dis 2006; 42:548-58; PMID:16421800; http://dx.doi.org/10.1086/499953
   PubMed Web of Science ®Google Scholar
• Bolger T, O'Connell M, Menon A, Butler K. Complications associated with the bacille Calmette-Guérin vaccination in Ireland. Arch Dis Child 2006; 91:594-7; PMID:16547086; http://dx.doi.org/10.1136/adc.2005.078972
   PubMed Web of Science ®Google Scholar
• Dourado I, Rios MH, Pereira SM, Cunha SS, Ichihara MY, Goes JC, Rodrigues LC, Bierrenbach AL, Barreto ML. Rates of adverse reactions to first and second doses of BCG vaccination: results of a large community trial in Brazilian schoolchildren. Int J Tuberc Lung Dis 2003; 7:399-402; PMID:12729348
   PubMed Web of Science ®Google Scholar
• Deeks SL, Clark M, Scheifele DW, Law BJ, Dawar M, Ahmadipour N, Walop W, Ellis CE, King A. Serious adverse events associated with bacille Calmette-Guérin vaccine in Canada. Pediatr Infect Dis J 2005; 24:538-41; PMID:15933565; http://dx.doi.org/10.1097/01.inf.0000164769.22033.2c
   PubMed Web of Science ®Google Scholar
• Dommergues MA, de La Rocque F, Guy C, Lécuyer A, Jacquet A, Guérin N, Fagot JP, Boucherat M, d'Athis P, Cohen R. Local and regional adverse reactions to BCG-SSI vaccination: a 12-month cohort follow-up study. Vaccine 2009; 27:6967-73; PMID:19800440; http://dx.doi.org/10.1016/j.vaccine.2009.09.073
   PubMed Web of Science ®Google Scholar
• Turnbull FM, McIntyre PB, Achat HM, Wang H, Stapledon R, Gold M, Burgess MA. National study of adverse reactions after vaccination with bacilli Calmette-Guérin. Clin Infect Dis 2002; 34:447-53; PMID:11797170; http://dx.doi.org/10.1086/338462
   PubMed Web of Science ®Google Scholar
• Hesseling AC, Marais BJ, Gie RP, Schaaf HS, Fine PE, Godfrey-Faussett P, Beyers N. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. Vaccine 2007; 25:14-8; PMID:16959383; http://dx.doi.org/10.1016/j.vaccine.2006.07.020
   PubMed Web of Science ®Google Scholar
• Tissot F, Zanetti G, Francioli P, Zellweger JP, Zysset F. Influence of bacilli Calmette-Guérin vaccination on size of tuberculin skin test reaction: to what size? Clin Infect Dis 2005; 40:211-7; PMID:15655737; http://dx.doi.org/10.1086/426434
   PubMed Web of Science ®Google Scholar
• Menzies D. What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us? Clin Infect Dis 2000; 31:S71-4; PMID:11010826; http://dx.doi.org/10.1086/314075
   PubMed Web of Science ®Google Scholar
• Tsolia MN, Mavrikou M, Critselis E, Papadopoulos NG, Makrinioti H, Spyridis NP, Metsou F, Tsagaraki M, Koulouri M, Kafetzis DA. Whole blood interferon-γ release assay is a useful tool for the diagnosis of tuberculosis infection particularly among Bacille Calmette Guèrin-vaccinated children. Pediatr Infect Dis J 2010; 29:1137-40; PMID:20616761; http://dx.doi.org/10.1097/INF.0b013e3181ebfe8a
   PubMed Web of Science ®Google Scholar
• Jacobs S, Warman A, Richardson R, Yacoub W, Lau A, Whittaker D, Cockburn S, Verma G, Boffa J, Tyrrell G, et al. The tuberculin skin test is unreliable in school children BCG-vaccinated in infancy and at low risk of tuberculosis infection. Pediatr Infect Dis J 2011; 30:754-8; PMID:21487326; http://dx.doi.org/10.1097/INF.0b013e31821b8f54
   PubMed Web of Science ®Google Scholar
• Piñeiro R, Mellado MJ, Cilleruelo MJ, García-Ascaso M, Medina-Claros A, García-Hortelano M. Tuberculin skin test in bacille Calmette-Guérin-vaccinated children: how should we interpret the results? Eur J Pediatr 2012; 171:1625-32; http://dx.doi.org/10.1007/s00431-012-1783-8
   PubMed Web of Science ®Google Scholar
• Boyzaykut A, Ipek IO, Ozkars MY, Seren LP, Atay E, Atay Z. Effect of BCG vaccine on tuberculin skin tests in 1-6-year-old children. Acta Paediatr 2002; 91:235-8; PMID:11952015; http://dx.doi.org/10.1111/j.1651-2227.2002.tb01701.x
   PubMed Web of Science ®Google Scholar